The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men

Inclusion Criteria: * A signed informed consent to participate in the study * Men aged 35 to 70 with testosterone levels below 12 nmol/L or free testosterone below 225 pmol/L * Presence of the metabolic syndrome according to the IDF definition Exclusion Criteria: * Patients under 35 or above 70 years. * Participation in any clinical study within 30 days before the first injection of the drug * Simultaneous participation in another clinical study * Incapable subjects as well as prisoners * Suspicion of a serious organic or mental disease according to medical history and/or clinical examination * Prostate cancer, breast cancer or suspicion thereof * Presence or history of hepatic tumors * Acute or chronic hepatic disease * Presence of renal diseases with renal failure * Changes in biochemical or hematological laboratory values in spite of lack of clinical manifestations, in the investigator's opinion * Suspected lack of the patient's compliance * Hypersensitivity to the active substance